NCT02716753

Brief Summary

All couples planned for IVF will be asked to participate. After information and received informed consent they will be randomized into two groups. At the time for ovum pick up during an IVF procedure either half of the amount of seminal plasma or the same amount of physiological NaCl solution will be installed around the external cervical opening in vagina. The syringe with seminal plasma or physiological NaCl solution will be prepared according to a prearranged randomization list by a technician. The success rate will be the number of diagnosed pregnancies and live births.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 23, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

October 2, 2023

Status Verified

September 1, 2023

Enrollment Period

6.3 years

First QC Date

March 17, 2016

Last Update Submit

September 29, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pregnancy rate

    Pregnancy as a viable fetus at ultrasonography around week 12 and delivery of baby

    40 weeks

Secondary Outcomes (1)

  • Cytokine content

    40 weeks

Study Arms (2)

Seminal plasma

EXPERIMENTAL

Half of the amount of seminal plasma received after preparation of the spermatozoa used for IVF will be deposited around the external cervical opening

Biological: seminal plasma

Physiological NaCL solution

PLACEBO COMPARATOR

An amount of physiological NaCL solution equal to half of the amount of seminal plasma received after preparation of the spermatozoa used for IVF will be deposited around the external cervical opening

Biological: Physiological NaCL solution

Interventions

seminal plasmaBIOLOGICAL
Seminal plasma
Physiological NaCL solution

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • subjects have given informed consent
  • infertility for at least 1 year
  • the couple wishing IVF
  • subjects aged between 20 - 40 years
  • azoospermia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Linköping, 581 85, Sweden

Location

Related Publications (1)

  • Liffner S, Bladh M, Rodriguez-Martinez H, Sydsjo G, Zalavary S, Nedstrand E. Intravaginal exposure to seminal plasma after ovum pick-up does not increase live birth rates after in vitro fertilization or intracytoplasmic sperm injection treatment: a double-blind, placebo-controlled randomized trial. Fertil Steril. 2024 Jul;122(1):131-139. doi: 10.1016/j.fertnstert.2024.02.002. Epub 2024 Feb 9.

MeSH Terms

Conditions

Infertility

Interventions

Seeds

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Elizabeth Nedstrand, PhD, Md

    Ostergotland County Council, Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

March 17, 2016

First Posted

March 23, 2016

Study Start

November 1, 2016

Primary Completion

March 1, 2023

Study Completion

March 1, 2023

Last Updated

October 2, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations